Exactly, Guts. Adding strong sales reps in a ripe market will be akin to compounding interest. I am confident that SCRC's compounding pharmacy business will provide like us investors with compounding returns beyond our expectations. I'm beginning to believe this little company tapped into an enormous mine of uncut diamonds. I was quite happy knowing that Bob would succeed with his mini-McKesson model (e.g., WRx and PIMD), but all of the information you have shared this weekend has me so excited that I might have to take some ambien to help me sleep tonight. Let's roll!